Syneos Health Inc - Class A
US ˙ NASDAQ ˙ US87166B1026
DIESES SYMBOL IST NICHT MEHR AKTIV

SecuritySYNH / Syneos Health Inc - Class A
InstitutionAperio Group, LLC
Latest Disclosed Ownership33,658 shares
Latest Disclosed Value $ 2,293,000
Aperio Group, LLC reports 94.34% increase in ownership of SYNH / Syneos Health Inc - Class A

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 33,658 shares of Syneos Health Inc - Class A (US:SYNH) valued at $2,293,120 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 17,319 shares of Syneos Health Inc - Class A. This represents a change in shares of 94.34% during the quarter. The current value of the position is $1,446,621 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F SYNEOS HEALTH CL A 87166B102 33,658 16,339 94.34 2,293 148.97 0.0068
2020-11-06 2020-09-30 13F SYNEOS HEALTH CL A 87166B102 17,319 358 2.11 921 -6.78 0.0031
2020-08-13 2020-06-30 13F SYNEOS HEALTH CL A 87166B102 16,961 -1,012 -5.63 988 39.55 0.0037
2020-05-05 2020-03-31 13F SYNEOS HEALTH CL A 87166B102 17,973 5,442 43.43 708 -4.97 0.0031
2020-02-13 2019-12-31 13F SYNEOS HEALTH CL A 87166B102 12,531 -224 -1.76 745 9.72 0.0027
2019-11-06 2019-09-30 13F SYNEOS HEALTH CL A 87166B102 12,755 2,371 22.83 679 27.87 0.0027
2019-07-30 2019-06-30 13F SYNEOS HEALTH CL A 87166B102 10,384 2,511 31.89 531 30.15 0.0022
2019-05-13 2019-03-31 13F SYNEOS HEALTH CL A 87166B102 7,873 484 6.55 408 40.21 0.0018
2019-05-06 2018-12-31 13F/A-1 SYNEOS HEALTH CL A 87166B102 7,389 678 10.10 291 -15.90 0.0015
2019-02-14 2018-12-31 13F SYNEOS HEALTH CL A 87166B102 7,869 1,158 310
2019-05-06 2018-09-30 13F/A-1 SYNEOS HEALTH CL A 87166B102 6,711 74 1.11 346 11.25 0.0015
2018-10-17 2018-09-30 13F SYNEOS HEALTH INC CL COMMON 87166B102 6,711 74 346
2019-05-06 2018-06-30 13F/A-1 SYNEOS HEALTH CL A 87166B102 6,637 -524 -7.32 311 22.44 0.0015
2018-07-30 2018-06-30 13F SYNEOS HEALTH INC CL COMMON 87166B102 6,637 -524 311
2019-05-01 2018-03-31 13F/A-1 SYNEOS HEALTH CL A ADDED 87166B102 7,161 -8,097 -53.07 254 -61.80 0.0013
2018-05-08 2018-03-31 13F SYNEOS HEALTH INC CL COMMON 87166B102 7,161 254
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.